Assessment of lupus: where are we now?
Decisions about treatment for patients with SLE are based on numerous criteria, including the rate of change of clinical features and disease markers (especially antibodies to dsDNA and markers of complement turnover), which organ systems are affected, the severity of manifestations, and the presenc...
Guardat en:
| Publicat a: | Ann Rheum Dis |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1993
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1005009/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8484667/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.3.169 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|